Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Other Liabilities

Acadia Pharmaceutica Other Liabilities Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Other Liabilities from 2010 to 2020.
  • Acadia Pharmaceutica Other Liabilities for the quarter ending June 06, 2020 was $5m a 52.17% increase of 2m year over year
  • Acadia Pharmaceutica Other Liabilities for the last 12 months ending June 06, 2020 was $5m a 52.17% increase of 2m year over year
  • Acadia Pharmaceutica Annual Other Liabilities for 2019 was $3m a 45.54% increase of 1m from 2018
  • Acadia Pharmaceutica Annual Other Liabilities for 2018 was $2m a 87.74% increase of 1m from 2017
  • Acadia Pharmaceutica Annual Other Liabilities for 2017 was $0m a 17.80% increase of 0m from 2016
Other Balance Sheet Metrics:
  • Acadia Pharmaceutica Total Assets for the quarter ending September 09, 2018 was $266m a -44.30% decrease of -118m year over year
  • Acadia Pharmaceutica Total Equity for the quarter ending September 09, 2018 was $223m a -50.06% decrease of -112m year over year
View Chart On Koyfin

Quarterly ACAD Other Liabilities Data

06/2020$5m
03/2020$3m
12/2019$3m
09/2019$2m
06/2019$1m
03/2019$1m
12/2018$2m
09/2018$1m
06/2018$1m
03/2018$1m

Annual ACAD Other Liabilities Data

2019$3m
2018$2m
2017$0m
2016$0m
2015$0m
2014$0m
2013$0m
2012$18m
2011$3m
2010$3m